
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
The Europe medical devices market is one of the largest and most sophisticated in the world, with a value of over â¬XX billion in 2022. The market is expected to reach a value of over â¬XX billion by 2030, growing at a CAGR of 5.5% from 2023 to 2030. This growth is driven by factors such as an aging population, increasing healthcare spending, and technological advancements.
The market is segmented based on device type, end-user, and geography. In vitro diagnostics (IVDs) constitute the largest market segment by device type, accounting for over 40% of the market in 2022. Other significant segments include medical imaging devices, surgical devices, and orthopedic devices.
Hospitals represent the largest end-user market for medical devices in Europe, capturing over 60% of the market in 2022. Home healthcare, ambulatory care, and long-term care facilities also constitute notable end-user segments.
Western Europe holds the position of the largest geographic market for medical devices in Europe, accounting for over 70% of the market in 2022. Central and Eastern Europe and Southern Europe also represent significant geographic markets.
Several key trends are fueling the growth of the Europe medical devices market. The aging population in Europe is driving up the demand for medical devices that can effectively manage chronic conditions and enhance the quality of life for older adults.
Healthcare spending in Europe is on the rise, providing greater funding for medical devices. This trend is being propelled by a combination of factors, including the aging population, the increasing prevalence of chronic diseases, and the rising cost of cutting-edge medical technologies.
Technological advancements are leading to the development of increasingly sophisticated medical devices. These devices are characterized by enhanced effectiveness, improved efficiency, and greater user-friendliness.
The market is transitioning towards personalized medicine, with devices tailored to individual patient needs. This shift is being driven by advances in genomics and other technologies that facilitate a deeper understanding of patient-specific health risks and requirements.
Payers are increasingly seeking medical devices that demonstrate value for money. This is driving a focus on devices that are clinically effective, cost-effective, and contribute to improved patient outcomes.
Despite its promising growth trajectory, the Europe medical devices market faces several challenges. Rising healthcare costs are putting pressure on medical device manufacturers to maintain low prices, posing a challenge for companies developing new and innovative devices, which often come with a higher cost tag.
Payers are increasingly demanding cost-effective medical devices. This is driving a focus on devices that deliver clinical effectiveness and improved patient outcomes while remaining affordable.
The European Union enforces stringent regulatory requirements for medical devices, aimed at ensuring patient safety and quality. This regulatory landscape poses a challenge for companies introducing new devices, as they must adhere to all applicable regulations.
Looking ahead, the Europe medical devices market is expected to continue its upward trajectory, driven by the factors mentioned above. The market is projected to surpass â¬XXX billion by 2030.
Companies that excel in developing innovative medical devices, expanding into new markets, and forming partnerships to expedite product introductions are well-positioned to thrive in the competitive Europe medical devices market.
A medical device is any device that can be used by people alone or in combination (as stated by the maker) for a medical purpose.
This includes any equipment, software, materials, or other items. The term "medical device" refers to several items, including breast implants, walking sticks, and contact lenses.
In vitro diagnostic devices are included in the category of medical devices. For example, blood glucose, lateral flow, and pregnancy tests, these medical instruments are used to test samples of tissue, bodily fluids, and blood that have been removed from the body.
Implantable medical devices, like cardiac pacemakers, are also considered medical devices; these devices are typically implanted and may or may not need external sources of power or functioning.
To learn more about Global Medical Devices Market, read our report
The Europe medical devices market is one of the largest and most sophisticated in the world, with a value of over â¬XXX billion in 2022. The market is expected to reach a value of over â¬XXX billion by 2030, growing at a CAGR of 5.5% from 2023 to 2030. This growth is being driven by factors such as an aging population, increasing healthcare spending, and technological advancements.
S.No. | Company Name | Timeline | Developments |
1 | Siemens Healthineers | 1847 - Present | ⢠Development of AI-powered CT scanner, Somatom DRIVE (2023) ⢠Partnership with companies for 3D printing solutions for dental applications (2023) ⢠Launch of wearable devices for diabetes management, including the Dexcom G7 continuous glucose monitoring (CGM) system (2022) ⢠Offer of a variety of robotic surgical systems, including the Mako Robotic-Arm Assisted Surgery System and the CorPath System (2023) |
2 | Philips Healthcare | 1891 - 2023 | ⢠Introduction of AI-powered MR scanner, Signa Architect (2022) ⢠Development of 3D printing solutions for orthopedic applications (2021) ⢠Launch of wearable devices for heart rate monitoring and sleep tracking (2023) ⢠Offer of robotic surgical systems for minimally invasive procedures (2023) ⢠Development of wirelessly connected medical devices for remote patient monitoring (2023) |
3 | Medtronic | 1949 - 2023 | ⢠Launch of closed-loop insulin delivery system for diabetes management (2021) ⢠Development of minimally invasive surgical devices for heart and vascular applications (2022) ⢠Offer of neurosurgical devices for treating brain and spinal cord disorders (2022) ⢠Introduction of wearable devices for monitoring patient activity and vital signs (2023) ⢠Development of a range of diagnostic devices for various medical conditions (2021) |
4 | GE Healthcare | 1896 - 2023 | ⢠Development of AI-powered ultrasound system, Logiq S8 (2021) ⢠Partnership with companies for 3D printing solutions for medical models (2022) ⢠Launch of wearable devices for monitoring respiratory health and fitness (2023) ⢠Offer of surgical navigation systems for image-guided procedures (2022) ⢠Development of advanced anesthesia delivery systems (2023) |
5 | Johnson & Johnson | 1885 - 2023 | ⢠Launch of robotic surgical system for minimally invasive procedures (2023) ⢠Development of 3D printing solutions for surgical planning and guidance (2022) ⢠Offer of a range of medical implants for orthopedic, cardiovascular, and neurological applications (2021) ⢠Introduction of wearable devices for tracking glucose levels and blood pressure (2023) ⢠Development of diagnostic devices for various medical conditions (2022) |
AI is rapidly being integrated into medical devices, with the potential to improve patient outcomes, reduce healthcare costs, and personalized medicine. AI-powered devices are being used for a variety of applications, including:
Robotics is another rapidly growing field in the medical devices market. Robotic devices are being used for a variety of applications, including:
The IoT is having a major impact on the medical devices market. IoT-enabled devices can be used to collect and transmit data about patients' health, which can then be used to improve patient care. For example, IoT-enabled devices can be used to monitor patients' blood sugar levels, medication adherence, and other vital signs.
3D printing is a rapidly growing technology that is being used to create customized medical devices. 3D printing can be used to create a variety of medical devices, including:
Wearable devices are becoming increasingly popular, as they can be used to track a variety of health metrics, such as heart rate, blood pressure, and sleep patterns. Wearable devices can also be used to monitor patients' adherence to medication regimens.
These are just a few of the many technological trends that are shaping the Europe medical devices market. These trends are having a major impact on the way medical devices are developed, manufactured, and used. They are also leading to the development of new and innovative medical devices that are improving patient care.
Siemens Healthineers AG is a German multinational conglomerate company headquartered in Berlin and Munich, that develops medical devices and software, diagnostics, and healthcare services. The company is one of the largest healthcare companies in the world and operates in over 70 countries.
Siemens Healthineers has launched a number of innovative medical devices in recent years. Some of the most notable launches include :
Siemens Healthineers is a leader in the development of new technologies and trends in the medical devices market. Some of the company's most recent innovations include:
Siemens Healthineers is using artificial intelligence to improve the accuracy of medical diagnoses, personalize treatment plans, and automate tasks and it is using data analytics to gain insights into patient populations and improve healthcare outcomes.
Siemens Healthineers is using 3D printing to create customized medical devices and implants, using robotics to develop minimally invasive surgical procedures and it is developing wirelessly connected medical devices that can be used to monitor patients' health remotely.
S.No. | Overview of Development | Development Detailing | Region of Development | Possible Future Outcomes |
1 | Artificial Intelligence (AI) in Medical Devices | AI algorithms are being used to analyze medical images, such as X-rays and CT scans, to detect abnormalities and make diagnoses. AI can also be used to develop personalized treatment plans for patients and monitor patients' health status. | Europe | - Improved patient outcomes |
Reduced healthcare costs
Personalized medicine Robotics in Medical Devices and robotic surgical systems are becoming increasingly popular, as they offer surgeons greater precision and control than traditional laparoscopic surgery. Robotic rehabilitation devices are being used to help patients regain mobility after injuries or strokes. - More precise and controlled surgeries
Improved patient outcomes
Reduced recovery times Internet of Things (IoT) in Medical Devices,| IoT-enabled devices can be used to collect and transmit data about patients' health, which can then be used to improve patient care.
For example, IoT-enabled devices can be used to monitor patients' blood sugar levels, medication adherence, and other vital signs - Improved patient monitoring
More timely interventions
Reduced healthcare costs 3D Printing in Medical Devices,3D printing is being used to create customized medical devices, such as prosthetics and implants, that fit each individual patient perfectly. 3D printing can also be used to create surgical guides that help surgeons perform operations more accurately.| - More personalized medical devices
Early detection of disease
Personalized interventions, Virtual Reality (VR), and Augmented Reality (AR) in Medical Devices.VR and AR are being used in a variety of medical applications, including pain management, rehabilitation, and training. - Improved pain management
More effective rehabilitation
Enhanced training for medical professionals
S.No. | Company Name | Timeline | Developments |
1 | Siemens Healthineers | 2023 | - Development of AI-powered CT scanner, Somatom DRIVE (2023) - Partnership with companies for 3D printing solutions for dental applications (2023) - Launch of wearable devices for diabetes management, including the Dexcom G7 continuous glucose monitoring (CGM) system (2022) - Offer of a variety of robotic surgical systems, including the Mako Robotic-Arm Assisted Surgery System and the CorPath System (2023) |
2 | Philips Healthcare | 2023 | - Introduction of AI-powered MR scanner, Signa Architect (2022) - Development of 3D printing solutions for orthopedic applications (2021) - Launch of wearable devices for heart rate monitoring and sleep tracking (2023) - Offer of robotic surgical systems for minimally invasive procedures (2023) - Development of wirelessly connected medical devices for remote patient monitoring (2023) |
3 | Medtronic | 2023 | - Launch of closed-loop insulin delivery system for diabetes management (2021) - Development of minimally invasive surgical devices for heart and vascular applications (2022) - Offer of neurosurgical devices for treating brain and spinal cord disorders (2022) - Introduction of wearable devices for monitoring patient activity and vital signs (2023) - Development of a range of diagnostic devices for various medical conditions (2021) |
4 | GE Healthcare | 2023 | - Development of AI-powered ultrasound system, Logiq S8 (2021) - Partnership with companies for 3D printing solutions for medical models (2022) - Launch of wearable devices for monitoring respiratory health and fitness (2023) - Offer of surgical navigation systems for image-guided procedures (2022) - Development of advanced anesthesia delivery systems (2023) |
5 | Johnson & Johnson | 2023 | - Launch of robotic surgical system for minimally invasive procedures (2023) - Development of 3D printing solutions for surgical planning and guidance (2022) - Offer of a range of medical implants for orthopedic, cardiovascular, and neurological applications (2021) - Introduction of wearable devices for tracking glucose levels and blood pressure (2023) - Development of diagnostic devices for various medical conditions (2022) |
New Technology: AI-powered MR scanner, Signa Architect
Explanation: The Signa Architect is an AI-powered MR scanner that uses artificial intelligence to improve image quality and reduce scan times. This can lead to more accurate diagnoses and improved patient care.
New Technology: Closed-loop insulin delivery system for diabetes management
Explanation: The closed-loop insulin delivery system is an automatic insulin delivery system that monitors a patient's blood sugar levels and adjusts insulin delivery accordingly. This can help to improve blood sugar control and prevent complications of diabetes.
New Technology: AI-powered ultrasound system, Logiq S8
Explanation: The Logiq S8 is an AI-powered ultrasound system that uses artificial intelligence to improve image quality and reduce the amount of time it takes to perform an ultrasound exam. This can lead to more efficient and accurate ultrasounds.
New Technology: Robotic surgical system for minimally invasive procedures
Explanation: The robotic surgical system is a minimally invasive surgical system that offers surgeons greater precision and control than traditional laparoscopic surgery. This can lead to shorter recovery times and fewer complications for patients.
New Technology: AI-powered CT scanner, Somatom DRIVE
Explanation: The Somatom DRIVE is an AI-powered CT scanner that uses artificial intelligence to improve image quality and reduce scan times. This can lead to more accurate diagnoses and improved patient care.
NBs and the European Commission have taken initiative by making decisions to support the industry and the population in fighting the virus. The medical device industry has been under tremendous pressure to deliver and innovate as a result of the current pandemic.
The rules governing CE marking for PPE and critically needed medical devices have been temporarily relaxed in some NBs, including those in Germany, the UK, and France. Since there is a shortage of these, countries must buy or import them even without CE marking.
Products must be marketed in the US, Canada, Australia, or Japan and have user manuals that are available in the local tongue in order to ensure that quality standards are met.
The majority of NBs have temporarily suspended their on-site audits and inspections, and they encourage businesses to adhere to the necessary requirements and Good Manufacturing Practice (GMP) recommendations.
Additional 180 oxygen concentrators, 2000 pulse oximeters, and other medical supplies have been given to outpatient units in Georgian villages thanks to funding from the European Union (EU).
The supplies were acquired as part of a significant EU-United Nations initiative to support rural healthcare facilities and lessen the effects of the COVID-19 outbreak in the nation. To increase access to healthcare, the initiative will eventually equip village ambulatory units with telemedicine technology.
The COVID-19 pandemic has also affected preparations for the EU Medical Device Regulation (2017/745) (MDR). Scientists and engineers who have been working on the new MDR framework for several years have switched to COVID-19-related research, while research and combat teams and research institutions and industry are building up additional research and production capacities to meet the increasing demands due to COVID-19.
The first manufacturing facility for Europe, the Middle East, and Africa (EMEA) was opened, according to Align Technology. In Polandâs Wroclaw, the regional facility was inaugurated. Along with the ones already in place in Ziyang, China, and Juarez, Mexico, it serves as Alignâs third regional manufacturing facility globally.
The cutting-edge facility will serve as an operations site for EMEA business, according to a news release from Align. The 80,000m2 structure complies with Align sustainability standards, including LEED and ISO14001 certifications. A component of Alignâs strategy to bring operational facilities closer to customers is represented by the facility.
BD plans to build a âhigh-techâ manufacturing facility in Zaragoza, Spain, which it believes will increase the continentâs output of drug delivery devices and generate up to 600 new jobs. The plant, which will be BDâs fourth production facility in Spain, will primarily produce prefilled syringes for the Europe medical device market.
The facility will increase production capacity for the needles and syringes that BD produces for the COVID-19 vaccines. A portion of that pandemic work is already being handled by BD from a different plant in Spain. 150 workers will be employed at the new 86,000-square-foot Zaragoza facility when it opens.
A new 20.000m2 manufacturing and R&D facility has been opened by Applied Medical, a multinational medical device company, at its European headquarters in Amersfoort, the Netherlands, as part of an expansion of its European operations.
European team members will design, develop, and manufacture Applied Medicalâs medical devices internally in accordance with the companyâs vertically integrated business model, which calls for distribution to clients throughout Europe, the Middle East, and Africa.
The mission of Applied Medical is to develop cutting-edge products that enhance patient outcomes and advance minimally invasive surgery. Applied Medical, a new generation medical device company, is equally dedicated to enhancing the accessibility and affordability of high-quality healthcare.
S.NO | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Research Methodology |
4 | Executive Summary |
5 | Average B2B by price |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Disruptive innovation in the Industry |
9 | Robotics for minimally invasive surgery |
10 | Cybersecurity challenges for medical devices |
11 | Ethical considerations of using AI in healthcare |
12 | Technology trends in the Industry |
13 | Consumer trends in the industry |
14 | Recent Production Milestones |
15 | Competition from substitute products |
16 | New product development in past 12 months |
17 | Market Size, Dynamics and Forecast by Product Type, 2024-2030 |
18 | Market Size, Dynamics and Forecast application, 2024-2030 |
19 | Market Size, Dynamics and Forecast by End user, 2024-2030 |
20 | Market Size, Dynamics and Forecast byRegion, 2024-2030 |
21 | Competitive landscape |
22 | Gross margin and average profitability of suppliers |
23 | M&A in past 12 months |
24 | Growth strategy of leading players |
25 | Market share of vendors, 2023 |
26 | Company Profiles |
27 | Unmet needs and opportunity for new suppliers |
28 | Conclusion |